Trademark: TALCEPTRX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for TALCEPTRX
We do not have any records of a proof of use for TALCEPTRX at this moment.
Possible trademark infringements of TALCEPTRX
Basic Information about TALCEPTRX
- Serial Number
- 86951722
- Filing Date
- 24 Mar 2016
- Registration Number
- 5607464
- Registration Date
- 13 Nov 2018
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TALCEPTRX on the blockchain with WikiTrademarks.io.
- First use of TALCEPTRX anywhere
- TALCEPTRX was first used on 27 Sep 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns TALCEPTRX?
1. ONCXERNA THERAPEUTICS, INC. WALTHAM MA
2. ONCOLOGIE, INC. Waltham MA
3. ONCOLOGIE, INC. Waltham MA
4. Oncologie, Inc. West Newton MA
5. Peregrine Pharmaceuticals, Inc. Tustin CA
6. Peregrine Pharmaceuticals, Inc. Tustin CA
Correspondent
- Monica Riva Talley
- Sterne, Kessler, Goldstein & Fox P.L.L.C
- 1100 New York Avenue, NW
- Washington DC 20005
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io